dithiothreitol has been researched along with Carotid Arteriopathies, Traumatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, B; Jiang, Q; Kapadia, MR; Kibbe, MR; Martinez, J; Tsihlis, ND; Vavra, AK | 1 |
| Flannery, WD; Jiang, Q; Kapadia, MR; Kibbe, MR; Oustwani, CS; Tsihlis, ND; Vavra, AK | 1 |
2 other study(ies) available for dithiothreitol and Carotid Arteriopathies, Traumatic
| Article | Year |
|---|---|
Nitric oxide decreases activity and levels of the 11S proteasome activator PA28 in the vasculature.
Topics: Analysis of Variance; Animals; Aorta; Carotid Arteries; Carotid Artery Injuries; Caspases; Cells, Cultured; Chymotrypsin; Cysteine; Dithiothreitol; Mercuric Chloride; Myocytes, Smooth Muscle; Nitric Oxide; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Reducing Agents; S-Nitrosothiols; Trypsin | 2012 |
Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature.
Topics: Animals; Carotid Artery Injuries; Cells, Cultured; Disease Models, Animal; Dithiothreitol; Down-Regulation; Endopeptidases; Glutathione; Humans; Hyperplasia; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Nitric Oxide; Nitric Oxide Donors; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Recombinant Proteins; S-Nitroso-N-Acetylpenicillamine; Time Factors; Ubiquitination; Vascular System Injuries | 2013 |